NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Phenotypical differences in clinical HIV/AIDS disease with Thailand HIV-1 genotypes A and B.

Weniger BG, Tansuphaswadikul S, Young NL, Pau CP, Lohsomboon P, Yindeeyoungyeon W, Limpakarnjanarat K; National Conference on Human Retroviruses and Related Infections.

Program Abstr First Natl Conf Hum Retrovir Relat Infect Natl Conf Hum Retrovir Relat Infect 1st 1993 Wash DC. 1993 Dec 12-16; 105.

Division of HIV/AIDS, CDC, Atlanta, GA.

Introduction: Comparison of clinical features of the two major, distinct HIV-1 genotypes in Thailand--AA and B--is made possible by peptide EIA serotyping which, if monoreactive, has 100% PVP for the true genotype. Methods: HIV+ outpatients (n=60) and inpatients (n=267) admitted 8/91-9/92 were serotyped, resulting in 216 type As and 73 type Bs for analysis (12 dual-reactors and 26 nonreactors were excluded). Results: Of 162 sexual risk-group patients, 99% (160) had HIV-1 type A, while 86% (66) of 77 IDUs had B. Type As had lower mean CD4+ levels (204/microliter, 11.4%) than Bs (310/microliter, 20.0%, p less than .001), with similar trend when stratified by sex and transmission mode. CD4+ levels less than 200/microliter or less than 14% occurred in 64% (133/209) of As and 44% (31/71) of Bs (p=.003). All 17 Pneumocystis diagnoses were in As (p less than .01), as were all 34 non-Candida mycoses (p less than .001), including two of Penicillium marneffei. However, TB occurred in fewer As (33%) than Bs (53%, p=.002). Inpatient fatality rate was 20% for A and 12% for B (p=.14). Conclusion: Thai HIV-1 types segregate markedly by transmission mode. Lower CD4+ levels and different opportunistic infections in type A vs. B may result from confounding or perhaps from real biological differences.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Anti-HIV Agents
  • Antigens, CD4
  • Genotype
  • HIV
  • HIV Envelope Protein gp120
  • HIV Infections
  • HIV Seronegativity
  • HIV Seropositivity
  • HIV Seroprevalence
  • HIV-1
  • Health Personnel
  • Humans
  • Serotyping
  • Thailand
  • genetics
  • immunology
Other ID:
  • 95921304
UI: 102214244

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov